Review

Nature Reviews Cancer 2, 910-917 (December 2002) | doi:10.1038/nrc950

The retinoblastoma tumour suppressor in development and cancer

Marie Classon1 & Ed Harlow2  About the authors

Top

Since its discovery, the retinoblastoma (RB) tumour-suppressor protein has been a focal point of cancer research. Accumulating evidence indicates a complex role for RB in cell proliferation, differentiation and survival. To further complicate matters, proteins that are related to RB have redundant as well as antagonistic functions. Recent studies of knockout mice and cells that lack one or more of these proteins have begun to clarify their various context-specific functions and the unique activity of this tumour suppressor.

Author affiliations

  1. MGH Cancer Center, Building 149, 13th Street, Room 7330, Charlestown, Massachusetts 02129, USA.
    Email: classon@helix.mgh.harvard.edu
  2. Harvard Medical School, 240 Longwood Avenue, Room 213, Boston, Massachusetts 02115, USA.
    Email: EHarlow@hms.harvard.edu
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated

NEWS AND VIEWS
Kip1 meets SKP2: new links in cell-cycle control
Nature Cell Biology News and Views (01 Aug 1999)

RESEARCH
E2F1 mediates ectopic proliferation and stage-specific p53-dependent apoptosis but not aberrant differentiation in the ocular lens of Rb deficient fetuses
Oncogene Original Article (07 Dec 2000)
Association with E2F-1 governs intracellular trafficking and polyubiquitination of DP-1
Oncogene Original Article (01 Feb 1999)
Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis
Oncogene Original Article (19 Oct 2000)
See all 73 matches for Research

Extra navigation

Subscribe

Subscribe to Nature Reviews Cancer

Search PubMed for

naturejobs

Advertisement